News Xencor, Inc.

Equities

XNCR

US98401F1057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
18.21 ^USD	-0.92%		-9.45%	-14.23%

Apr. 16	BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating	MT
Apr. 09	Xencor Names Bart Cornelissen as Chief Financial Officer	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating	Apr. 16	MT
Xencor Names Bart Cornelissen as Chief Financial Officer	Apr. 09	MT
Xencor Appoints Bart Cornelissen as Chief Financial Officer	Apr. 09	BU
Xencor, Inc. Announces CFO Changes	Apr. 09	CI
Xencor Appoints Bart Cornelissen as Senior Vice President	Apr. 09	CI
USTPO Issues Means-Plus-Function Memorandum	Mar. 27	AQ
Transcript : Xencor, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 11:15 AM	Mar. 14
Xencor Insider Sold Shares Worth $293,519, According to a Recent SEC Filing	Mar. 07	MT
North American Morning Briefing : Fed's Preferred -2-	Feb. 29	DJ
Xencor to Present at Upcoming Investor Conferences	Feb. 28	BU
Wedbush Adjusts Xencor's Price Target to $34 From $36, Keeps Outperform Rating	Feb. 28	MT
Transcript : Xencor, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Xencor: Q4 Earnings Snapshot	Feb. 27	AQ
Earnings Flash (XNCR) XENCOR Posts Q4 Revenue $44.7M, vs. Street Est of $74.7M	Feb. 27	MT
Xencor, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 27	BU
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update	Feb. 20	BU
Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi	Feb. 19	AQ
Xencor Insider Sold Shares Worth $1,048,743, According to a Recent SEC Filing	Feb. 14	MT
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab	Feb. 06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xencor, Inc.

Equities

XNCR

US98401F1057

Summary

Filters